StockNews.AI
DIS
StockNews.AI
75 days

BetterInvesting™ Magazine Update on The Walt Disney Co. (NYSE: DIS)

1. Disney chosen as 'Stock to Study' for August 2025 issue. 2. Investors questioning if Disney stock is overvalued or in buy range. 3. Fundamental data highlights Disney's sales, earnings, and profitability metrics. 4. BetterInvesting provides tools for evaluating Disney's financial health. 5. Investment committee advises further study on Disney's stock performance.

5m saved
Insight
Article

FAQ

Why Bullish?

Being selected as a 'Stock to Study' may increase investor interest in DIS, similar to past cases where such recognitions correlated with price appreciation.

How important is it?

The article identifies Disney for further analysis, suggesting future price movements depending on perception from potential investors.

Why Long Term?

The stock's emphasis in educational content could positively affect its valuation over time as more investors become aware and engage with its metrics.

Related Companies

AMGN
, /PRNewswire/ -- Based on recent updated information, the Securities Review Committee of BetterInvesting Magazine has revised its previous decision pertaining to Stride Inc.'s announced selection as the "Stock to Study" for the August 2025 issue. The Walt Disney has been chosen instead as the "Stock to Study" for August. The Walt Disney Co.'s recent report has investors wondering if the company's stock is overvalued. Or is it in the buy range? As such, the Editorial Advisory and Securities Review Committee of BetterInvesting Magazine consider Disney (NYSE:DIS) as worthy of further study and has named the company its "Stock to Study" for the August 2025 issue for investors' informational and educational use. The fundamental data is eye-opening; investors can view Disney's sales, earnings, pre-tax profit, return on equity, and more all on one page, courtesy of the National Association of Investors Corp., at: https://ssg.betterinvesting.org/trial/ssgplus/?studyid=16958122. A full report on Disney will appear in the August 2025 issue of BetterInvesting Magazine.  The same issue of BetterInvesting Magazine will also include a fundamental review of Amgen Inc.  (AMGN: NASDAQ), which the independent Editorial Advisory and Securities Review Committee believes is worthy of further study from an undervalued perspective.  Committee members are Daniel J. Boyle, CFA; Marisa Bradbury, CFA; Philip Keating, CFA; Walter J. Kirchberger, CFA; Anne Nichols, CFA; and Dan Rutter, CFA. Doron P. Levin, an editor of the magazine, serves as the committee's chairperson. Securities mentioned are for study and presented for educational purposes only. They are not to be considered as endorsed or recommended for purchase by NAIC/BetterInvesting. Investors should conduct their own review and analysis of any company of interest using the Stock Selection Guide before making an investment decision. About BetterInvesting: BetterInvesting™, a national 501(c)(3) nonprofit, investment education organization, has been empowering everyday Americans since 1951. Also known as the National Association of Investors™ (NAIC®), we have helped more than 5 million people from all walks of life learn how to improve their financial future. BetterInvesting provides unbiased, in-depth investing education and powerful online stock analysis tools to create successful lifelong investors. BetterInvesting staff, along with a dedicated community of volunteers across America, teach the organization's principles and time-tested methodology to individuals and investment clubs. For more information about BetterInvesting, please visit www.betterinvesting.org Follow us on LinkedIn, Instagram and Facebook. Contact: 877-275-6242 SOURCE NAIC-BetterInvesting WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM? 440k+ Newsrooms & Influencers 9k+ Digital Media Outlets 270k+ Journalists Opted In

Related News